Dividends & Buybacks · Jun 26, 2026

HCW Biologics Inc. approved a 1-for-6 reverse stock split effective June 30, 2026, to maintain compliance with…

HCWBHCW Biologics Inc.

HCW Biologics Inc. approved a 1-for-6 reverse stock split effective June 30, 2026, to maintain compliance with Nasdaq's minimum bid price rule. The split will automatically convert shares into a new CUSIP and a new adjusted basis for trading on Nasdaq under the symbol HCWB. HCW Biologics Inc. is a biotechnology company focused on developing biologics and cell-based therapies.